GlassScriptPhysician profile
Christopher Hajnosz
NPI 1134398134
$12,357.34
in general payments reported to CMS, 2019-2025
45 companies · $2,595 in 2025
The $2,595 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,414 · 2020: $324 · 2021: $2,471 · 2022: $3,386 · 2023: $412 · 2024: $1,754 · 2025: $2,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,973 · Education: $1,500 · Travel and Lodging: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,973.23 |
| Education | $1,500.00 |
| Travel and Lodging | $1,288.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $2,000.00 | 2021-2022 | |
| Access Pro Medical, LLC | $1,909.73 | 2025 | Matriderm |
| Anika Therapeutics, INC. | $1,707.86 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $1,254.22 | 2019-2024 | |
| Smith+Nephew, INC. | $1,173.54 | 2019-2025 | Grafix Pl, Stravix, Renasys Go V2 Home |
| Grt US Holding, INC. | $725.98 | 2021-2022 | |
| Arthrex, INC. | $675.63 | 2019-2024 | |
| Organogenesis INC. | $573.01 | 2019-2024 | Puraply Antimicrobial, Puraply |
| Misonix INC | $206.27 | 2019-2021 | |
| Bioventus LLC | $202.67 | 2019-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $189.13 | 2019-2022 | |
| Integra Lifesciences Corporation | $168.65 | 2019-2022 | |
| Stryker Corporation | $157.13 | 2020-2025 | 7 X 23mm Citrelock Implant |
| Boston Scientific Corporation | $132.87 | 2023 | Eluvia |
| Triad Life Sciences INC. | $103.17 | 2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $94.91 | 2021 | |
| Horizon Therapeutics Plc | $85.96 | 2019-2022 | |
| Rmr Ortho INC | $84.07 | 2025 | A'Tomic |
| W. L. Gore & Associates, INC. | $75.87 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Zimmer Biomet Holdings, INC. | $64.22 | 2019 | |
| Abbott Laboratories | $63.05 | 2019-2023 | Proclaim |
| Melinta Therapeutics, LLC | $58.33 | 2019 | |
| Amgen INC. | $53.47 | 2024-2025 | Krystexxa |
| Nabriva Therapeutics, Plc | $47.47 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $46.40 | 2022-2025 | Nuzyra |
| Lifenet Health | $45.40 | 2023-2025 | Theragenesis Wound Matrix |
| Kci USA, INC. | $41.18 | 2019-2022 | |
| Alfasigma USA, INC. | $40.95 | 2020-2021 | |
| Nevro Corp. | $37.83 | 2021-2022 | |
| Davol INC. | $34.40 | 2020 | |
| Abbvie INC. | $28.38 | 2022 | |
| Tactile Systems Technology INC | $27.24 | 2020-2022 | |
| Assertio Therapeutics, INC. | $25.95 | 2019 | |
| Fusion Orthopedics USA, LLC | $23.63 | 2024 | |
| Reprise Biomedical, INC. | $23.14 | 2024 | Miro3d |
| Cardinal Health 200 LLC | $22.11 | 2019 | |
| Ethicon US, LLC | $19.79 | 2021 | |
| Hartmann USA, INC. | $19.43 | 2025 | Zetuvit Plus 10x10 P10 |
| Medtronic, INC. | $19.41 | 2024 | Intellis Adaptivestim |
| Aroa Biosurgery Incorporated | $17.59 | 2023 | |
| Baudax Bio INC. | $17.41 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.95 | 2022 | |
| Merck Sharp & Dohme LLC | $14.81 | 2019 | |
| Axogen | $14.39 | 2019 | |
| Orthofix Medical, INC. | $13.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hajnosz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.